Plant Summary

  Plant Information

TCMBank_ID:

TCMBANKHE004578

ID:

TCMBANKHE004578

植物拉丁名:

Melilotus suaveolens
显示图片

功能与主治:

To clear summerheat and transform damp, fortify stomach and harmonize center./Summerheat-damp and oppression in chest, distended head and headache, dysentery, malaria, strangury syndrome, vaginal discharge, mouth sore, bad breath, sores, damp sore, scab and lichen, scrofula.

药用植物名:

辟汗草

药用部位:

whole herb

TCM_ID_id:

2137

   植物对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN000028 coumarin KBio3_002764; HSDB 1623; NSC284685; Spectrum5_000555; AC1L7KKB; SPECTRUM1400208; WLN: T66 BOVJ; 2H-Benzo[b]pyran-2-one; cis-o-Coumarinic acid lactone; BRN 0383644; Benzo-a-pyrone; BSPBio_003263; Spectrum_001336; o-Hydroxyzimtsaure-lacton [German]; 6-(1,2-DIHYDROXY-3-METHYL-3-BUTENYL)-7-METHOXYCOUMARIN; 2H-chromen-2-one; NSC-284685; 1,2-benzopyrone; Thamnosmonin; 2H-1-Benzopyran-2-one; 2H-1-Benzopyran, 2-oxo-; 2-chromenone; Benzo-.alpha.-pyrone; NSC8774; Cumarin; 91-64-5; 6-(1,2-dihydroxy-3-methyl-but-3-enyl)-7-methoxy-chromen-2-one; C05851; o-hydroxycinnamic acid delta-lactone; 28150_FLUKA; Coumarin; COUMARIN (I); Tonka bean camphor; Spectrum2_000303; KBio2_006952; Cinnamic acid, o-hydroxy-, delta-lactone; InChI=1/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6; o-Hydroxycinnamic lactone; 6-7-methoxy-2h-1-benzopyran-2-one; NSC 8774; NSC-220196; NSC220196; SMR000059040; NCGC00091502-04; NCGC00091502-01; CHEMBL498094; 6-(1,2-dihydroxy-3-methylbut-3-enyl)-7-methoxychromen-2-one; Coumarinic lactone; Kumarin [Czech]; 6-(1,2-DIHYDROXY-3-METHYLBUT-3-EN-1-YL)-7-METHOXYCHROMEN-2-ONE; Cinnamic acid, o-hydroxy-, .delta.-lactone; Spectrum3_001772; Rattex; chromen-2-one; 2-Propenoic acid, 3-(2-hydroxyphenyl)-, .delta.-lactone; NCGC00091502-02; 2H-1-Benzopyran-2-one, 6-(1,2-dihydroxy-3-methyl-3-butenyl)-7-methoxy-; D03ZMQ; C4261_SIGMA; W526509_ALDRICH; NCI C07103; SBB000094; 5-17-10-00143 (Beilstein Handbook Reference); NCGC00091502-03; SPBio_000266; 2-Oxo-1,2-benzopyran; 2-Propenoic acid, 3-(2-hydroxyphenyl)-, delta-lactone; AIDS-009326; NCGC00091502-05; coumarin ; CHEBI:28794; EINECS 202-086-7; CCRIS 181; CTK5B0978; 5,6-Benzo-alpha-pyrone; 2-Propenoic acid, 3-(2-hydroxyphenyl)-delta-lactone; ZINC00074709; o-Hydroxycinnamic acid lactone; KBio2_004384; COU; AIDS009326; Benzo-alpha-pyrone; Coumarin, Chinese; o-Coumaric acid lactone; KBioGR_002460; Coumarinic anhydride; 2-Propenoic acid, 3-(2-hydroxyphenyl)-, d-lactone; SDCCGMLS-0066912.P001; KBioSS_001816; KBio2_001816; 3-(2-Hydroxyphenyl)-2-propenoic delta-lactone; 1-Benzopyran-2-one; Coumarine; NCI60_041938; 2H-Benzopyran-2-one; 1,2-Benzopyrone; MLS000028741; 5,6-Benzo-2-pyrone; 2H-Benzo(b)pyran-2-one; EPA Pesticide Chemical Code 127301; cis-o-Coumaric acid anhydride; Spectrum4_001818; 60094-90-8; Caswell No. 259C; AI3-00753 C9H6O2 146.14 C1=CC=C2C(=C1)C=CC(=O)O2
TCMBANKIN004456 dihydromelilotoside CHEMBL1087938; AC1NSUKW; 3-[2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]propanoic acid; Dihydromelilotoside; BDBM50310449 C15H20O8 328.31 g/mol C1=CC=C(C(=C1)CCC(=O)O)OC2C(C(C(C(O2)CO)O)O)O
TCMBANKIN013906 coumarinic acid cis-2-coumaric acid; (2Z)-3-(2-hydroxyphenyl)prop-2-enoate; coumarinicacid; (2Z)-3-(2-hydroxyphenyl)acrylate; (2Z)-3-(2-hydroxyphenyl)acrylic acid; cis-2-Hydroxycinnamate; coumarinate; cis-2-hydroxycinnamic acid; CHEBI:47921; cis-2-coumarate C9H7O3- 163.15 g/mol C1=CC=C(C(=C1)C=CC(=O)O)[O-]
TCMBANKIN025059 3,4-Heptadiene 1,3-Diethylallene; hepta-3,4-diene C10H19N 153.26 CCC=C=CCC
TCMBANKIN032689 Eseramine UNII-PE4VD738WT; AC1MJ1L1; N-methylcarbamic acid [(3aS,8bS)-4,8b-dimethyl-3-(methylcarbamoyl)-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] ester; BDBM50022773; [(3aS,8bS)-4,8b-dimethyl-3-(methylcarbamoyl)-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate; 6091-57-2; (3aS-cis)-3,3a,8,8a-Tetrahydro-N,3a,8-trimethyl-5-[[(methylamino)carbonyl]oxy]-pyrrolo[2,3-b]indole-1(2H)-carboxamide; C09170; CHEMBL77799; eseramine; PE4VD738WT; Pyrrolo(2,3-b)indole-1(2H)-carboxamide, 3,3a,8,8a-tetrahydro-N,3a,8-trimethyl-5-(((methylamino)carbonyl)oxy)-, (3aS-cis)-; Methyl-carbamic acid 3a,8-dimethyl-1-methylcarbamoyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indol-5-yl ester; [(8bS)-4,8b-dimethyl-3-(methylcarbamoyl)-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate C16H22N4O3 318.37 CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC)C)C(=O)NC
TCMBANKIN043270 p-Coumaric acid CHEBI:32373; Para-Coumaric acid; ZB001183; trans-4-Hydroxycinnamic acid; (E)-3-(4-Hydroxyphenyl)-2-propenoic acid; 2-propenoic acid, 3-(4-hydroxyphenyl)-, (2E)-; Naringeninic acid; p-Cumaric acid; CHEBI:36090; p-Coumaric acid,trans; 501-98-4; (E)-3-(4-hydroxyphenyl)acrylic acid; trans-4-coumarate; 4'-Hydroxycinnamic acid; 4-(2-Carboxyethenyl)phenolate; HC4; trans-4-hydroxycinnamate; trans-p-Coumarinic acid; 4-hydroxycinnamate anion; 3-(4-hydroxyphenyl)acrylic acid; (2E)-3-(4-hydroxyphenyl)prop-2-enoic acid; 3-(4-hydroxyphenyl)prop-2-enoate; trans-p-Hydroxycinnamic acid; (E)-3-(4-hydroxyphenyl)prop-2-enoate; (E)-p-Hydroxycinnamic acid; 3-(4-hydroxyphenyl)acrylate; trans-4-coumaric acid; trans-p-Coumaric acid; (2E)-3-(4-hydroxyphenyl)acrylate; 4-10-00-01005 (Beilstein Handbook Reference); C00811; (2E)-3-(4-hydroxyphenyl)acrylic acid; BRN 2207383; CHEBI:12876; beta-(4-Hydroxyphenyl)acrylic acid; Para coumaric acid; COUMARATE; MLS001066419; 28200_FLUKA; p-Hydroxyphenylacrylic acid; Cinnamic acid, p-hydroxy-; 4-Coumaric acid; InChI=1/C9H8O3/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-6,10H,(H,11,12; 7400-08-0; beta-[4-hydroxyphenyl]acrylic acid; A828008; p-coumaricacid; SBB007613; 4-Hydroxycinnamate; Cinnamic acid, p-hydroxy-, (E)-; SMR000112201; 0-10-00-00297 (Beilstein Handbook Reference); CINNAMIC ACID,4-HYDROXY P-COUMARIC ACID; (E)-p-Coumaric acid; AIDS027710; CJ-00262; (2E)-3-(4-hydroxyphenyl)prop-2-enoate; 2-Propenoic acid, 3-(4-hydroxyphenyl)-; ZINC00039811; .beta.-[4-Hydroxyphenyl]acrylic acid; p-coumaric acid ; AC1NRBN2; InChI=1/C9H8O3/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-6,10H,(H,11,12)/b6-3; trans-p-coumarate; (E)-3-(4-hydroxyphenyl)prop-2-enoic acid; 4-Oxylatocinnamate; p-Hydroxycinnamic acid; HYDROXYCINNAMIC ACID; EINECS 231-000-0; BRN 2207381; NSC 674321; Enamine_005378; 4-Hydroxycinnamic acid; CHEBI:32374; NSC674321; AIDS-027710; 2-Propenoic acid, 3-(4-hydroxyphenyl)-, (E)- (9CI); NSC59260; p-coumarate; (E)-3-(4-hydroxyphenyl)-2-propenoate; C9008_SIGMA; 3-(4-Hydroxyphenyl)-2-propenoic acid; 3-(4-hydroxyphenyl)prop-2-enoic acid; 4-coumarate; NSC 59260 C9H8O3 164.158 c1([H])c([H])c(O[H])c([H])c([H])c1\C([H])=C([H])\C(=O)O[H]
TCMBANKIN058197 o-coumaric acid-beta-d-glucoside o-coumaricacid-β-d-glucoside C1=CC(=CC=C1C=CC(=O)O)OC2C(C(C(C(O2)CO)O)O)O
TCMBANKIN058272 esculetin AIDS-014709; CCG-38509; Cichoriin aglycon; KBioSS_001646; KUC108669N; NSC-26428; ZINC00057908; SM2XD6V944; HMS1570L22; ILEDWLMCKZNDJK-UHFFFAOYSA-N; NSC26428; Esculetol; ZX-AN021876; BPBio1_000968; MolPort-000-709-311; 6,7-Dihydroxycoumarin, 8CI; FCH1117729; ST24044991; 6,7-dihydroxy-2-chromenone; Coumarin, 6,7-dihydroxy-; NCGC00094873-01; KBio1_001374; NCGC00016425-01; Prestwick1_000940; AS-11863; LS-55161; CHEBI:490095; 2H-1-BENZOPYRAN-2-ONE,6,7-DIHYDROXY; RTR-013104; KSC-11-243-1; 7H-1-Benzopyran-7-one, 2,6-dihydroxy-; Esculetol); W-2566; DTXSID3075383; KS-0000017Z; 2,6-Dihydroxy-7H-chromen-7-one; NCGC00016425-04; Cichoriin aglucon; Spectrum5_000512; CD-051; ZX-AFC000486; BG01504928; KSC148K7L; SR-01000721907-2; HMS1921M14; ACM305356; E0386; Aesculetin (cichorigenin; NSC 26428; Aesculetin; s4711; EBD2197580; NCGC00016425-05; NCGC00094873-02; AK591206; AN-44203; BRN 0152788; 6,7-dihydroxy-2H-chromen-2-one; Esculatin; KBio2_006782; AB00489955; GTPL5180; SCHEMBL24641; 6,7-Dihydroxycoumarin; ACMC-20luwt; SR-01000721907; Esculin aglycon; SPECTRUM1500899; MFCD00006874; Cichorigenin; BIB6051; UNII-SM2XD6V944; I14-1622; BDBM34571; ST5306833; CHEMBL244743; TR-013104; MLS000069479; CAS-305-01-1; 6,7-Dihydroxy-2-chromenone; SMR000059055; C09263; 6,7-dihydroxychromen-2-one; esculetin ; HMS3373K09; DivK1c_006430; 3.05E+13; E-3401; HMS2233G24; InChI=1/C9H6O4/c10-6-3-5-1-2-9(12)13-8(5)4-7(6)11/h1-4,10-11; SpecPlus_000334; Spectrum4_001886; MCULE-4460039316; Esculetin; AC1NQYFH; Prestwick2_000940; A820407; Prestwick3_000940; Oprea1_719746; 6,7-bis(oxidanyl)chromen-2-one; Asculetine; ST079379; KBioGR_002416; AIDS014709; AC-18400; AKOS030559695; 91753-33-2; CJ-00486; KBio3_001584; FT-0620854; SMP2_000093; 305-01-1; AB0010898; 5-18-03-00202 (Beilstein Handbook Reference); CE0046; KBio2_001646; BSPBio_000880; Spectrum2_000586; 6,7-Dihydroxy-2H-1-benzopyran-2-one; SC-45867; DB-014626; CC-22332; BSPBio_002364; CTK3G3670; SDCCGMLS-0066669.P001; ALBB-023362; SPBio_000432; AC1Q7980; 6,7-Dihydroxy-2-benzopyrone; Prestwick0_000940; AJ-09788; C-06350; NCGC00016425-03; AK114506; 6,7-Dihydroxycoumarin, 98%; ZINC57908; EINECS 206-161-5; cid_5281416; BRD-K58149231-001-06-9; 2H-1-Benzopyran-2-one, 6,7-dihydroxy-; bmse000986; 4CN-0872; 6,7-dihydroxy-1-benzopyran-2-one; BN0888; HMS2097L22; Bio-0588; SPBio_003049; C9H6O4; E-3400; KBio2_004214; Spectrum_001166; Esculetin, analytical standard; 2H-1-Benzopyran-2-one, 6,7-dihydroxy- (9CI); N1764; 6,7-DIHYDROXYCOUMARIN; Coumarin, 6,7-dihydroxy- Esculetin; J10146; Esculetin, European Pharmacopoeia (EP) Reference Standard; 246573_ALDRICH; ZB002263; Esculin aglucon; 6,7-dihydroxy-coumarin; KB-50565; NCI60_002119; ANW-43483; 6,7-Dihydroxy-2H-chromen-2-one; D0YZ5G; NCGC00016425-06; Jsp005751; AX8020100; AKOS000276955; NCGC00016425-02; CCRIS 7065; 6,7-Dihydroxy-2H-chromen-2-one #; Spectrum3_000752; 6, 7-dihydroxycoumarin; aesculetin; 6,7-dihydroxycoumarin; 6,7-dihydroxy coumarin; CCG-38509; Cichoriin aglycon; KBioSS_001646; KUC108669N; NSC-26428; SM2XD6V944; HMS1570L22; ILEDWLMCKZNDJK-UHFFFAOYSA-N; NSC26428; Esculetol; ZX-AN021876; BPBio1_000968; MolPort-000-709-311; 6,7-Dihydroxycoumarin, 8CI; FCH1117729; ST24044991; Coumarin, 6,7-dihydroxy-; NCGC00094873-01; KBio1_001374; NCGC00016425-01; Prestwick1_000940; AS-11863; LS-55161; CHEBI:490095; 2H-1-BENZOPYRAN-2-ONE,6,7-DIHYDROXY; RTR-013104; KSC-11-243-1; 7H-1-Benzopyran-7-one, 2,6-dihydroxy-; Esculetol); W-2566; DTXSID3075383; KS-0000017Z; 2,6-Dihydroxy-7H-chromen-7-one; NCGC00016425-04; Cichoriin aglucon; Spectrum5_000512; CD-051; ZX-AFC000486; BG01504928; KSC148K7L; SR-01000721907-2; HMS1921M14; ACM305356; E0386; Aesculetin (cichorigenin; NSC 26428; Aesculetin; s4711; EBD2197580; NCGC00016425-05; NCGC00094873-02; AK591206; AN-44203; BRN 0152788; Esculatin; KBio2_006782; AB00489955; GTPL5180; SCHEMBL24641; ACMC-20luwt; SR-01000721907; Esculin aglycon; SPECTRUM1500899; MFCD00006874; Cichorigenin; BIB6051; UNII-SM2XD6V944; I14-1622; BDBM34571; CHEMBL244743; TR-013104; MLS000069479; CAS-305-01-1; 6,7-Dihydroxy-2-chromenone; SMR000059055; C09263; 6,7-dihydroxychromen-2-one; HMS3373K09; DivK1c_006430; 3.05E+13; E-3401; HMS2233G24; InChI=1/C9H6O4/c10-6-3-5-1-2-9(12)13-8(5)4-7(6)11/h1-4,10-11; SpecPlus_000334; Spectrum4_001886; MCULE-4460039316; Esculetin; AC1NQYFH; Prestwick2_000940; A820407; Prestwick3_000940; Oprea1_719746; 6,7-bis(oxidanyl)chromen-2-one; Asculetine; ST079379; KBioGR_002416; AC-18400; AKOS030559695; 91753-33-2; CJ-00486; KBio3_001584; FT-0620854; SMP2_000093; 305-01-1; AB0010898; 5-18-03-00202 (Beilstein Handbook Reference); CE0046; KBio2_001646; BSPBio_000880; Spectrum2_000586; 6,7-Dihydroxy-2H-1-benzopyran-2-one; SC-45867; DB-014626; CC-22332; BSPBio_002364; CTK3G3670; SDCCGMLS-0066669.P001; ALBB-023362; SPBio_000432; AC1Q7980; 6,7-Dihydroxy-2-benzopyrone; Prestwick0_000940; AJ-09788; C-06350; NCGC00016425-03; AK114506; 6,7-Dihydroxycoumarin, 98%; ZINC57908; EINECS 206-161-5; cid_5281416; BRD-K58149231-001-06-9; 2H-1-Benzopyran-2-one, 6,7-dihydroxy-; bmse000986; 4CN-0872; 6,7-dihydroxy-1-benzopyran-2-one; BN0888; HMS2097L22; Bio-0588; SPBio_003049; C9H6O4; E-3400; KBio2_004214; Spectrum_001166; Esculetin, analytical standard; 2H-1-Benzopyran-2-one, 6,7-dihydroxy- (9CI); N1764; 6,7-DIHYDROXYCOUMARIN; Coumarin, 6,7-dihydroxy- Esculetin; J10146; Esculetin, European Pharmacopoeia (EP) Reference Standard; ZB002263; Esculin aglucon; 6,7-dihydroxy-coumarin; KB-50565; NCI60_002119; ANW-43483; 6,7-Dihydroxy-2H-chromen-2-one; D0YZ5G; NCGC00016425-06; Jsp005751; AX8020100; AKOS000276955; NCGC00016425-02; CCRIS 7065; 6,7-Dihydroxy-2H-chromen-2-one #; Spectrum3_000752 C9H6O4 178.14 g/mol C1=CC(=O)OC2=CC(=C(C=C21)O)O
TCMBANKIN058273 aesculin;esculin Esculin hydrate, >=98%; SR-01000633930; CHEBI:73111; DTXSID60583344; Esculin hydrate; SMR001562115; A-D-glucopyranoside; Esculetin-6-; CHEMBL1718108; (-)-ESCULIN HYDRATE; AKOS025310104; Esculin sesquihydrate; SCHEMBL829959; Esculin monohydrate; 7-hydroxy-2-oxo-2H-chromen-6-yl beta-D-glucopyranoside--water (1/1); FT-0625710; C15H16O9.xH2O; Esculin sesquihydrate, p.a., 98%; C15H18O10; SR-01000633930-4; SC-21492; 340.2821 (anhydrous basis); MLS002695944; Esculin hydrate, analytical standard; Esculin hydrate, >=98.0% (HPLC); BG01647212; A-7671; AS-11688; 7-Hydroxy-2-oxo-2H-1-benzopyran-6-yl beta-D-glucopyranoside--water (1/1); MFCD00149492; MolPort-003-665-735; 66778-17-4; Esculin sesquihydrate, tested according to DAB;NINDS_000956; 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-2-one; Spectrum3_000731; Esculoside; AIDS002655; DivK1c_000956; SPBio_000392; SMP1_000008; 7-hydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-1-benzopyran-2-one hydrate; KBio2_003409; 7-hydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-2-chromenone; ZINC03860441; Spectrum4_001923; 2H-1-Benzopyran-2-one, 6-(.beta.-D-glucopyranosyloxy)-7-hydroxy-; Crataegin; Polychrom; 6,7-Dihydrocoumarin-6-glucoside; HMS3373P07; KBio3_001502; KBio2_005977; Esculetin 6-b-D-glucoside; SDCCGMLS-0066653.P001; Bicolorin; SPECTRUM1500901; Escosyl; KBio2_000841; Spectrum2_000576; 531-75-9; BCBcMAP01_000202; AIDS-002655; Polychrome; IDI1_000956; Esculetin 6-O-glucoside; 81320_FLUKA; Polychrome solution; KBioGR_002266; Enallachrome; Esculin; Vitamin C2; 6-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-7-oxidanyl-chromen-2-one hydrate; KBioSS_000841; Esculine; Spectrum_000361; KBio1_000956; A829428; BSPBio_002282; Spectrum5_000845; C09264; 6-(.beta.-D-Glucopyranosyloxy)-7-hydroxy-2H-1-benzopyran-2-one; 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one; 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-coumarin; STOCK1N-51823; SR-01000633930-1; 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-2-one C15H16O9 340.28 g/mol C1=CC(=O)OC2=CC(=C(C=C21)OC3C(C(C(C(O3)CO)O)O)O)O
TCMBANKIN058278 o-coumaricacid o-coumaric acid;trans-o-coumaric acid;2-Hydroxycinnamic acid;2-Coumarate;(2E)-3-(2-hydroxyphenyl)-2-propenoic acid; (E)-3-(2-Hydroxyphenyl)-2-propenoic acid; (2E)-3-(2-HYDROXYPHENYL)ACRYLIC ACID; 3-(2-hydroxyphenyl)prop-2-enoic acid; trans-2-Hydroxycinnamic acid; trans-2-coumaric acid; 2-propenoic acid, 3-(2-hydroxyphenyl)-; ST5331812; (2E)-3-(2-hydroxyphenyl)prop-2-enoic acid; 4-10-00-00999 (Beilstein Handbook Reference); 2-Coumaric acid; trans-2-Hydroxycinnamate; InChI=1/C9H8O3/c10-8-4-2-1-3-7(8)5-6-9(11)12/h1-6,10H,(H,11,12; 2-hydroxycinnamic acid; EINECS 210-386-4; 2-Propenoic acid, 3-(2-hydroxyphenyl)-, (E)- (9CI); (E)-3-(2-hydroxyphenyl)acrylic acid; 583-17-5; (E)-o-Hydroxycinnamic acid; (E)-2-hydroxycinnamic acid; 2HC; CINNAMIC ACID,2-HYDROXY (TRANS); CHEBI:18176; 2-Propenoic acid, 3-(2-hydroxyphenyl)-, (E)-; 2-Propenoic acid, 3-(2-hydroxyphenyl)-, (2E)-; C01772; CHEBI:18125; 28170_FLUKA; Cinnamic acid, o-hydroxy-, (E)-; EINECS 209-500-5; BRN 1100900; trans-o-Coumaric acid; o-Hydroxy-trans-cinnamic acid; CCRIS 5834; C03549; NSC 32952; H22809_ALDRICH; trans-o-Hydroxycinnamic acid; 614-60-8; WLN: QV1U1R BQ; Cinnamic acid, o-hydroxy-; NSC32952; (E)-3-(2-hydroxyphenyl)prop-2-enoic acid; 3-(2-hydroxyphenyl)acrylic acid; 2-Hydroxycinnamic acid, (E)-; 2-Hydroxycinnamic acid, predominantly trans; o-Coumaric acid C9H8O3 164.16 g/mol C1=CC=C(C(=C1)C=CC(=O)O)O
TCMBANKIN058279 coumarinic acid-beta-d-glucoside coumarinicacid-β-d-glucoside;(E)-3-[2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-enoic acid; trans-beta-D-glucosyl-2-hydroxycinnamic acid; 2-Propenoic acid, 3-(2-(beta-D-glucopyranosyloxy)phenyl)-, (E)-; (2E)-3-[2-(beta-D-glucopyranosyloxy)phenyl]prop-2-enoic acid; C05158; beta-D-Glucosyl-2-coumarate; (E)-3-[2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl]prop-2-enoic acid; (E)-3-[2-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]phenyl]prop-2-enoic acid; (2E)-3-[2-(beta-D-glucopyranosyloxy)phenyl]acrylic acid; (E)-3-[2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxyphenyl]acrylic acid; ACon1_000252; MEGxp0_001978; trans-beta-D-Glucosyl-2-hydroxycinnamate; 618-67-7; CHEBI:17531;Melilotoside C15H18O8 326.3 C1=CC=C(C(=C1)C=CC(=O)O)OC2C(C(C(C(O2)CO)O)O)O
TCMBANKIN058283 MELILOTATE C01198; 3-(2-hydroxyphenyl)propanoic acid; 3-(2-Hydroxyphenyl) propanoic acid; Melilotic acid; Oprea1_380863; 495-78-3; 3-(o-Hydroxyphenyl) propionic acid; 3-(2-Hydroxyphenyl) propionate; 2-hydroxybenzenepropanoic acid; 393533_ALDRICH; Benzenepropanoic acid, 2-hydroxy-; 3-(2-hydroxyphenyl)propanoate; InChI=1/C9H10O3/c10-8-4-2-1-3-7(8)5-6-9(11)12/h1-4,10H,5-6H2,(H,11,12; AIDS017764; AIDS-017764; ST5406932; 3-(2-Hydroxyphenyl)propionic acid; o-Hydroxyphenylpropionic acid; .beta.-(O-Hydroxyphenyl)propionic acid; CHEBI:16104; C9H10O3 166.17 g/mol C1=CC=C(C(=C1)CCC(=O)O)O
TCMBANKIN058365 dicoumarin SBI-0051343.P003; DSSTox_RID_76296; Kumoran; AS-19619; Z57170530; KBio2_000645; BSPBio_000890; Dicumarolo; 3,3'-Metilen-bis(4-idrossi-cumarina); Prestwick_90; LS-55258; NC 034; 3,3''''''''-methylenebis(4-hydroxy-coumarin; 4-hydroxy-3-[(4-hydroxy-2-oxo-chromen-3-yl)methyl]chromen-2-one; Spectrum3_000387; 3,3'-Methylenebis[4-hydroxy-2H-1-benzopyran-2-one]; 2H-1-Benzopyran-2-one],3'-methylenebis[4-hydroxy-; AC1L19PT; 3,3'-methanediylbis(4-hydroxy-2H-chromen-2-one); C00796; DSSTox_GSID_21729; Bio-0616; CHEMBL43154; Coumarin, 3,3'-methylenebis[4-hydroxy- (8CI); AB00051966_05; Prestwick0_000785; CHEBI:4513; Antitrombosin; STK801287; AC1Q699Q; UNII-7QID3E7BG7; Cumid; HMS502M18; Dwukumarol; D02TJS; 4-hydroxy-3-[(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-2H-chromen-2-one; 3,3'-Methylenebis[4-hydroxy-1,2-benzopyrone]; DOBMPNYZJYQDGZ-UHFFFAOYSA-N; Prestwick3_000785; H2893; Spectrum_000165; HMS1570M12; 3,3'-Methylene-bis(4-hydroxycoumarin); bis-hydroxycoumarin; NCGC00016296-04; Dicoumarolum [INN-Latin]; SPBio_000248; MFCD00006857; 5-19-06-00682 (Beilstein Handbook Reference); 3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one); 3,2-benzopyrone]; Pharmakon1600-01500239; NCGC00094650-02; 3,3'-Methylene-bis(4-hydroxycoumarin), 99%; NSC-17860; Dicumol; CHEMBL1466; CTK5C5178; Temparin; GTPL6808; KBio2_003213; VZ31493; Dicumarol [INN-Spanish]; NSC17860; 3,3'-Methylene-bis(4-hydroxycoumarine) [French]; MolPort-000-422-589; Coumarin, 3,3'-methylenebis[4-hydroxy-(8CI); W-203471; Cuma; IDI1_000896; NCGC00016296-02; 3,3'-Methyleen-bis(4-hydroxy-cumarine); 3,3'-Methyleen-bis(4-hydroxy-cumarine) [Dutch]; HY-N0645; 3,3′-Methylenebis(4-hydroxycoumarin); MCULE-8095183287; SCHEMBL33892; HMS2091M10; 3,3'-methylenebis(4-hydroxy-2H-chromen-2-one); Dicumarol, United States Pharmacopeia (USP) Reference Standard; Dicumarolum; Dicumarolo [DCIT]; 3,3''''''''-methylenebis(4-hydroxycoumarin); NCGC00094650-01; 3,3'-Methylene-bis(4-hydroxycoumarine); SPBio_002829; NSC 41834; Di-4-hydroxy-3,3'-methylenedicoumarin; 2H-1-Benzopyran-2-one,3'-methylenebis[4-hydroxy-; Prestwick1_000785; FT-0624734; NCGC00016296-03; NINDS_000896; DivK1c_000896; Dicumarinum; Di-(4-hydroxy-3-coumarinyl)methane; SR-05000001605; 3,3'-Metilen-bis(4-idrossi-cumarina) [Italian]; CCG-34550; 2H-1-Benzopyran-2-one, 3,3'-methylenebis(4-hydroxy-; NSC 221570; SR-05000001605-1; Dufalone; EINECS 200-632-9; Dicoumarol; NCGC00016296-01; Trombosan; HMS1920E20; Dicoumarol (INN); Tox21_110357; 2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy-(9CI); 3,3'-Methylene-bis[4-hydroxycoumarin]; Dicumarol [USAN]; NCGC00016296-07; ChemDiv2_003436; 3,3'-methylenebis(2-hydroxy-4h-chromen-4-one); M0216; Apekumarol; Dicoumal; SPECTRUM1500239; AI3-14546; KBioGR_001055; DB00266; 3,3'-Methylen-bis(4-hydroxy-cumarin); 66-76-2; I14-52299; 4,4'-Dihydroxy-3,3'-methylene bis coumarin; BSPBio_002173; Oprea1_150990; SR-05000001605-3; Dicumarol (TN); BBL008904; BPBio1_000980; HMS3714M12; NSC756733; BG01624449; KBioSS_000645; BRD-K82236179-001-05-0; melitoxin; 3,3 -Methylene-bis[4-hydroxycoumarin]; NCGC00016296-05; Coumarin,3'-methylenebis[4-hydroxy-; Dwukumarol [Polish]; Acavyl; Spectrum4_000508; 3,3-Methylene-bis[4-hydroxycoumarin]; AK325302; Bis(4-hydroxycoumarin-3-yl)methane; D03798; Dicumarol (USAN); dicoumarol; Dikumarol; 2H-1-Benzopyran-2-one, 3,3'-methylenebis(4-hydroxy)-; KBio3_001393; SR-05000001605-4; DSSTox_CID_1729; Baracoumin; 2-hydroxy-3-[(2-hydroxy-4-oxochromen-3-yl)methyl]chromen-4-one; CAS-66-76-2; Dicumarol [USAN:USP]; CBDivE_003005; BDBM35525; Tox21_110357_1; NSC-756733; 3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone); Dicuman; Acadyl; 4-hydroxy-3-((4-hydroxy-2-oxo-2H-chromen-3-yl)methyl)-2H-chromen-2-one; SCHEMBL33891; Dicumaol R; 4-hydroxy-3-[(4-hydroxy-2-oxochromen-3-yl)methyl]chromen-2-one; WLN: T66 BOVJ EQ D1- DT66 BOVJ EQ; NSC 17860; Dicoumarol [INN]; KBio1_000896; Dicoumerol; 3,3'-Methylen-bis(4-hydroxy-cumarin) [German]; NSC221570; Dicumarine; BRN 0335444; Spectrum5_000871; Bis-3,3'-(4-hydroxycoumarinyl)methane; dicumarol; Coumarin, 3,3'-methylenebis(4-hydroxy-; CCRIS 3713; 7QID3E7BG7; KBio2_005781; Y1603; 2H-1-Benzopyran-2-one), 3,3'-methylenebis(4-hydroxy-; CS-7962; Dicoumarolum; HSDB 3223; Prestwick2_000785; 3,3''''''''-methylenebis[4-hydroxycoumarin; DTXSID8021729; s4299; 3,3'-Methylenebis(4-hydroxycoumarin); ZINC3869855; 2H-1-Benzopyran-2-one,3,3'-methylenebis[4-hydroxy-; C19H12O6; 2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy- (9CI); 3,3'-Methylenebis[4-hydroxycoumarin]; Anathrombase; NSC41834; 3,3′ HMS3652P10; BG00665451; symmetric dicoumarol analogue, 1; AKOS000520650; Bis-3,3'-(4-oxycoumarinyl)ethylacetate; HMS1378M04; HMS2097M12; 2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy-; uncoupler of oxidative respiration; Spectrum2_000144; Bishydroxycoumarin;dicoumarol C19H12O6 336.3 g/mol C1=CC=C2C(=C1)C(=C(C(=O)O2)CC3=C(C4=CC=CC=C4OC3=O)O)O
TCMBANKIN058394 coumarin KBio3_002764; HSDB 1623; coumari; NSC284685; Spectrum5_000555; AC1L7KKB; SPECTRUM1400208; WLN: T66 BOVJ; 2H-Benzo[b]pyran-2-one; cis-o-Coumarinic acid lactone; BRN 0383644; Benzo-a-pyrone; BSPBio_003263; Spectrum_001336; o-Hydroxyzimtsaure-lacton [German]; 6-(1,2-DIHYDROXY-3-METHYL-3-BUTENYL)-7-METHOXYCOUMARIN; 2H-chromen-2-one; NSC-284685; 1,2-benzopyrone; Thamnosmonin; 2H-1-Benzopyran-2-one; 2H-1-Benzopyran, 2-oxo-; 2-chromenone; Benzo-.alpha.-pyrone; NSC8774; Cumarin; 91-64-5; 6-(1,2-dihydroxy-3-methyl-but-3-enyl)-7-methoxy-chromen-2-one; C05851; o-hydroxycinnamic acid delta-lactone; 28150_FLUKA; Coumarin; COUMARIN (I); Tonka bean camphor; Spectrum2_000303; KBio2_006952; Cinnamic acid, o-hydroxy-, delta-lactone; InChI=1/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6; o-Hydroxycinnamic lactone; 6-7-methoxy-2h-1-benzopyran-2-one; NSC 8774; NSC-220196; NSC220196; SMR000059040; NCGC00091502-04; NCGC00091502-01; CHEMBL498094; 6-(1,2-dihydroxy-3-methylbut-3-enyl)-7-methoxychromen-2-one; Coumarinic lactone; Kumarin [Czech]; 6-(1,2-DIHYDROXY-3-METHYLBUT-3-EN-1-YL)-7-METHOXYCHROMEN-2-ONE; Cinnamic acid, o-hydroxy-, .delta.-lactone; Spectrum3_001772; Rattex; chromen-2-one; 2-Propenoic acid, 3-(2-hydroxyphenyl)-, .delta.-lactone; NCGC00091502-02; 2H-1-Benzopyran-2-one, 6-(1,2-dihydroxy-3-methyl-3-butenyl)-7-methoxy-; D03ZMQ; C4261_SIGMA; W526509_ALDRICH; NCI C07103; SBB000094; 5-17-10-00143 (Beilstein Handbook Reference); NCGC00091502-03; SPBio_000266; 2-Oxo-1,2-benzopyran; 2-Propenoic acid, 3-(2-hydroxyphenyl)-, delta-lactone; AIDS-009326; NCGC00091502-05; coumarin ; CHEBI:28794; EINECS 202-086-7; CCRIS 181; CTK5B0978; 5,6-Benzo-alpha-pyrone; 2-Propenoic acid, 3-(2-hydroxyphenyl)-delta-lactone; ZINC00074709; o-Hydroxycinnamic acid lactone; KBio2_004384; COU; AIDS009326; Benzo-alpha-pyrone; Coumarin, Chinese; o-Coumaric acid lactone; KBioGR_002460; Coumarinic anhydride; 2-Propenoic acid, 3-(2-hydroxyphenyl)-, d-lactone; SDCCGMLS-0066912.P001; KBioSS_001816; KBio2_001816; 3-(2-Hydroxyphenyl)-2-propenoic delta-lactone; 1-Benzopyran-2-one; Coumarine; NCI60_041938; 2H-Benzopyran-2-one; 1,2-Benzopyrone; MLS000028741; 5,6-Benzo-2-pyrone; 2H-Benzo(b)pyran-2-one; EPA Pesticide Chemical Code 127301; cis-o-Coumaric acid anhydride; Spectrum4_001818; 60094-90-8; Caswell No. 259C; AI3-00753 C9H6O2 146.14 C1=CC=C2C(=C1)C=CC(=O)O2
TCMBANKIN058398 BZF WLN: T56 BOJ; NCGC00091088-01; 1-Oxindene; 1-Oxidene; NCGC00091088-03; CCRIS 2384; Coumaron; Benzo(b)furan; NSC 1255; InChI=1/C8H6O/c1-2-4-8-7(3-1)5-6-9-8/h1-6; EINECS 205-982-6; Cumarone; FR-0548; Benzo[b]furan; Benzofuran (IUPAC); 1-benzofuran; Coumarone; ZINC01591814; CHEBI:35260; HSDB 4173; Benzofuran; Benzofurfuran; B8002_ALDRICH; BRN 0107704; AI3-17613; SB 00762; 271-89-6; NSC1255; 5-17-02-00003 (Beilstein Handbook Reference); 2,3-Benzofuran; NCGC00091088-02; NCI-C56166; C14512 C8H6O 118.13 g/mol C1=CC=C2C(=C1)C=CO2
TCMBANKIN058686 (±)-2,3-dihydro-2-(1-methylethenyl)-5-benzofurancarboxylicacid methyl ester C13H14O3 CC(=C)C1CC2=C(O1)C=CC(=C2)C(=O)OC
TCMBANKIN058840 angelin umbelliprenin2021/11/13; 532-16-1; (E,E)-7-((3,7,11-Trimethyl-2,6,10-dodecatrienyl)oxy)-2H-1-benzopyran-2-one; ZINC02126785; 7-[(2E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]coumarin; 7-(3,7,11-trimethyldodeca-2,6,10-trienoxy)coumarin; 7-[(2E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]-2-chromenone; 7-(3,7,11-trimethyldodeca-2,6,10-trienoxy)-2-chromenone; 7-(3,7,11-trimethyldodeca-2,6,10-trienoxy)chromen-2-one; A1784/0075600; 7-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]coumarin; 30413-87-7; 7-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]-2-chromenone; 7-[(2E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]chromen-2-one; 7-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]chromen-2-one C24H30O3 366.5 g/mol CC(=CCCC(=CCCC(=CCOC1=CC2=C(C=C1)C=CC(=O)O2)C)C)C
TCMBANKIN060023 cembrene;1,3,6,10-Cyclotetradecatetraene, 14-isopropyl-3,7,11-trimethyl C20H32 272.47 CC1=CCCC(=CCC=C(C=CC(CC1)C(C)C)C)C
   植物对应的疾病
疾病ID 病名 疾病类型 MeSH 参考文献
   植物对应的靶点
靶点ID 基因名 基因别名 描述 染色体位置 Map_Location 基因类型

Home | Browse | Search | Predict | Data | Contact | Help

Copyright © KUST | 滇ICP备16009434号-1 | Dai SX Lab